Presentation from SCA Interim Report Q2 2014
0 likes2,467 views
The SCA interim report for Q2 2014 highlights stable tissue demand in Europe and growth in emerging markets, particularly for personal care products. The report details a strong organic sales growth, a significant increase in EBIT and operating margin, as well as several new product launches and strategic business integrations, including a joint venture in Australia and a transfer of hygiene business to Vinda in China. Overall, the document presents a positive outlook with improved sales, profits, and operational efficiency compared to Q2 2013.
Presentation from SCA Interim Report Q2 2014
- 1. SCA Interim Report Q2 2014
- 2. Tissue Stable demand for tissue in Europe Some growth for AfH tissue in North America Increased demand in emerging markets Personal Care Stable demand for personal care products in Europe Increased demand in emerging markets Forest Products Decreased demand for publication papers in Europe Improved market for solid-wood products in Europe July 18, 2014 SCA Interim Report Q2 2014 2 Q2 2014 Market Update
- 3. July 18, 2014 SCA Interim Report Q2 2014 3 Summary Q2 2014 vs. Q2 2013 Stable market demand in mature markets and higher market demand in emerging markets Good organic sales growth Strong increase of EBIT and EBIT-margin Efficiency programs delivering according to plan Several launches of new innovations and products Libero, Libresse, TENA and Tork Floated joint venture in Australia, New Zealand and Fiji SCA and Vinda to integrate hygiene business in China
- 4. SCA to transfer its hygiene business in China (Mainland China, Hong Kong and Macau) to Vinda Exclusive license for Vinda to market and sell SCA brands; TENA, Tork, Tempo, Libero and Libresse in China Vinda to acquire SCA’s Dr P and Sealer brands in China Benefits in distribution, sales, innovation and R&D Vinda gets access to a broader product portfolio and SCA brands, reaching broader consumer and customer base SCA’s hygiene business in China had net sales of approx. SEK 600m in 2013 Purchase consideration amounts to approx. SEK 1,000m Subject to approval by the shareholders of Vinda July 18, 2014 SCA Interim Report Q2 2014 4 SCA and Vinda to integrate hygiene business in China
- 5. Group Q2 2014 vs. Q2 2013 July 18, 2014 SCA Interim Report Q2 2014 5 Organic Sales Growth Operating Profit* Operating Margin* Operating Cash FlowEPS Sales * Excluding items affecting comparability and including gains on forest swaps of SEK 175m (0) before tax SEK 25,829m +12% SEK 2,934m +29% 11.4% +150 bp SEK 2.54 +56% SEK 2,060m +28% +3%
- 6. Innovations and Product Launches Q2 2014 Libresse Multistyle Liners / CurveFitTM Libero Comfort / Up&Go New Libresse Multistyle, the most absorbent liners designed to fit any style of knickers Curvefit liners, uniquely shaped to perfectly fit body shape for maximum comfort Comfort: Elastics smoother and softer around the legs, improved fit with better comfort Up&Go: Improved fit adjusts to baby’s unique body, softly following in every move. High absorption capacity to secure optimal leakage protection Global relaunch of TENA Lady and Lady pants Feminine designed Lady pants allowing consumers to choose from a family of TENA Lady range fitted for the needed occasion – discrete & secure July 18, 2014 SCA Interim Report Q2 2014 6 TENA Lady / Lady Pants
- 7. July 18, 2014 SCA Interim Report Q2 2014 7 Innovations and Product Launches Q2 2014 Tork - Bloe Tork - EasyCubeTM Tork Sanitizing Wet Wipe IT-based washroom service Provides easily accessible real- time data on toilet use Facilitates cleaning, control odors and reduce water usage IT-based washroom service Provides easily accessible real- time data on refill consumption Gives instant overview of when and where cleaning is needed Wet wipes for cleaning and sanitizing restaurant tables Discreet and portable solution
- 8. July 18, 2014 SCA Interim Report Q2 2014 8 Group Q2 2014 vs. Q2 2013 Sales growth 12% Organic sales growth of 3% All business areas show organic sales growth Good growth for the hygiene business in emerging markets Good growth for Forest Products Operating profit increased 29%* Organic operating profit growth 11%** Better price/mix Higher volumes Cost savings Acquisition in China Gains on forest swaps Higher raw material costs Operating margin increased 150 bp to 11.4%* Higher margin in Tissue and Forest Products Operating cash flow increased 28% Operating Profit Q2 2014 Operating Margin 9.9% 11.4% SEK 2,278m * Excluding items affecting comparability and including gains on forest swaps of SEK 175m (0) before tax ** Excluding items affecting comparability, exchange rate effects, acquisition in China and gains on forest swaps Q2 2013 Q2 2014Q2 2013 SEK 2,934m
- 9. Organic sales growth 3.3% Price/Mix +2% Volume +1% July 18, 2014 SCA Interim Report Q2 2014 9 Net sales Q2 2013 Price/Mix Volume Acquisition Currency Net sales Q2 2014 +2% +1% +2% SEK 23,119m +7% SEK 25,829m Net Sales Q2 2014 vs. Q2 2013 + 12%
- 10. Group Organic Sales Growth Q2 2014 vs. Q2 2013 Total Mature Markets Emerging Markets July 18, 2014 SCA Interim Report Q2 2014 By region Emerging markets Strong growth in Eastern Europe, Russia and Latin America - Feminine care in Latin America +19% - Incontinence products in Latin America +23% - Incontinence products in Russia +29% - Tissue in Russia +22% Mature markets Low growth in mature markets - AfH tissue in Western Europe +5% 10 +3% +1% +9%
- 11. SEK millions Q2 Q2 Change unless otherwise stated 2014 2013 % Net sales 25,829 23,119 12 Operating profit* 2,934 2,278 29 Operating margin* (%) 11.4 9.9 Profit before tax* 2,739 2,051 34 Earnings per share (SEK) 2.54 1.63 56 Operating cash flow 2,060 1,606 28 Debt/Equity ratio 0.56 0.54 Q2 2014 Results July 18, 2014 SCA Interim Report Q2 2014 11 * Excluding items affecting comparability and including gains on forest swaps of SEK 175m (0) before tax
- 12. Personal Care Q2 2014 vs Q2 2013 July 18, 2014 SCA Interim Report Q2 2014 12 * Excluding items affecting comparability Sales growth 4% Organic sales growth 4% Price/mix +2% Volume +2% Strong growth in emerging markets Growth in all product segments Strong growth for feminine care Operating profit decreased 3%* Better price/mix Higher volumes Cost savings Higher raw material costs Negative transaction exchange rate effects due to weakened currencies in emerging markets Operating margin 11.3%* Net Sales Operating Profit* Q2 2014Q2 2013 Q2 2014Q2 2013 Q2 2014Q2 2013 Operating Margin* SEK 7,750mSEK 7,475m SEK 877m SEK 902m 12.1% 11.3% Organic Sales Growth by Region Organic Sales Growth by Product Segment Incontinence Products Baby Diapers Feminine Care TotalMature Market Emerging Market Total +3% +4% +2% +11% +0% +9% +4%
- 13. Tissue Q2 2014 vs Q2 2013 July 18, 2014 SCA Interim Report Q2 2014 13 * Excluding items affecting comparability Sales growth 18% Organic sales growth 2% Price/mix +1% Volume +1% Strong growth in emerging markets Good growth for AfH tissue Operating profit increased 24%* Better price/mix Higher volumes Cost savings Acquisition in China Lower raw material and energy costs Operating margin 11.8%* Net Sales Operating Profit* Q2 2014Q2 2013 Q2 2014Q2 2013 Q2 2014Q2 2013 Operating Margin* SEK 14,039m SEK 11,930m SEK 1,652m SEK 1,333m 11.2% 11.8% Organic Sales Growth by Region Organic Sales Growth by Product Segment Consumer Tissue AfH Tissue TotalMature Market Emerging Market Total +0% +5% +2% 0% +8% +2%
- 14. Forest Products Q2 2014 vs Q2 2013 July 18, 2014 SCA Interim Report Q2 2014 14 * Excluding items affecting comparability and including gains on forest swaps of SEK 175m (0) before tax Q2 2014 Sales growth 11% Price/mix +6% Volume +4% Currency +1% Growth in all product segments Operating profit increased 149%* Higher prices Cost savings Gains on forest swaps Higher energy costs Higher harvesting costs Operating margin 14.8%* Net Sales Operating Profit* Q2 2014Q2 2013 Q2 2014Q2 2013 Q2 2014Q2 2013 Operating Margin* SEK 3,788m SEK 4,217m SEK 250m 6.6% 14.8%SEK 623m
- 15. July 18, 2014 SCA Interim Report Q2 2014 15 Summary Q2 2014 vs. Q2 2013 Stable market demand in mature markets and higher market demand in emerging markets Good organic sales growth Strong increase of EBIT and EBIT-margin Efficiency programs delivering according to plan Several launches of new innovations and products Libero, Libresse, TENA and Tork Floated joint venture in Australia, New Zealand and Fiji SCA and Vinda to integrate hygiene business in China
- 16. July 18, 2014 SCA Interim Report Q2 2014 16 Q&A